Oscar Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD 198.05 M

Oscar Health, Inc. EBITDA is USD 198.05 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 2,847.16% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Oscar Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 6.72 M, a -101.27% change year over year.
  • Oscar Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -530.92 M, a -1.45% change year over year.
  • Oscar Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -538.72 M, a 42.37% change year over year.
  • Oscar Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -378.39 M.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)